Xanadu Bio

Gladwyne, United States

Xanadu Bio is a nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology.

$11.0M raised

Sep 2025

Series B

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Xanadu Bio

How much funding has Xanadu Bio raised?

Xanadu Bio has raised $11.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.

Where is Xanadu Bio headquartered?

Xanadu Bio is headquartered in Gladwyne, United States.

What does Xanadu Bio do?

Xanadu Bio is a nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology.

What stage is Xanadu Bio at?

Xanadu Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 15, 2025.

MLA

"Xanadu Bio — Funding & Investors." VCBacked, September 15, 2025, https://www.vcbacked.co/company/xanadu-bio. Accessed June 17, 2026.

APA

VCBacked. (2025). Xanadu Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/xanadu-bio

Wikipedia (cite web)

{{cite web |title=Xanadu Bio — Funding & Investors |url=https://www.vcbacked.co/company/xanadu-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 15, 2025.